NCT00083109View on ClinicalTrials.gov

Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

March 31, 2008

Conditions
Recurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
Interventions
DRUG

Fluorouracil

Given IV

OTHER

Pharmacological Study

Correlative studies

DRUG

Suramin

Given IV

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00083109 - Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer | Biotech Hunter | Biotech Hunter